TABLE 1.
Baseline characteristics
| Characteristic | Result in hypericin dosage group
|
|
|---|---|---|
| 0.05 mg/kg (n = 12) | 0.1 mg/kg (n = 7) | |
| Mean age ± SD (yr) | 48 ± 7 | 45 ± 4 |
| Gender (no.) | ||
| Male | 10 | 5 |
| Female | 2 | 2 |
| Race or ethnic group (no.) | ||
| Black | 4 | 4 |
| Caucasian | 6 | 2 |
| Hispanic | 2 | 1 |
| Mean serum ALT level ± SD (U/liter)ab | 73 ± 34 | 75 ± 42 |
| Mean plasma HCV RNA level ± SD (log10 RNA molecules/ml)b | 7.17 ± 0.84 | 7.60 ± 0.47 |
a
Normal laboratory value = 0 to 45 U/liter.
b
Serum ALT results as well as plasma HCV RNA results obtained at the prescreening visit (within 7 days of baseline) and on the day of treatment initiation were averaged in order to obtain the baseline value.